Pediatrics
Partner With Us
Advertisement
Conexiant chevron_right Pediatrics chevron_right Dupilumab for Pediatric EoE Phase III Histologic Remission Findings
From the Journals

Dupilumab for Pediatric EoE: Phase III Histologic Remission Findings

Researchers found that dupilumab improved histologic remission in pediatric patients with eosinophilic esophagitis.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.